GE HealthCare Technologies Inc. (NASDAQ:GEHC) Shares Sold by Aviso Wealth Management

Aviso Wealth Management lowered its stake in GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 2.5% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 20,004 shares of the company’s stock after selling 522 shares during the quarter. Aviso Wealth Management’s holdings in GE HealthCare Technologies were worth $1,564,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also recently bought and sold shares of the stock. Graney & King LLC bought a new stake in shares of GE HealthCare Technologies in the 4th quarter worth $75,000. Trust Investment Advisors boosted its holdings in shares of GE HealthCare Technologies by 55.5% in the fourth quarter. Trust Investment Advisors now owns 8,350 shares of the company’s stock worth $653,000 after buying an additional 2,979 shares during the period. TIAA Trust National Association raised its holdings in shares of GE HealthCare Technologies by 2.8% during the fourth quarter. TIAA Trust National Association now owns 10,604 shares of the company’s stock valued at $829,000 after acquiring an additional 291 shares during the period. Modern Wealth Management LLC purchased a new stake in shares of GE HealthCare Technologies in the 4th quarter valued at approximately $187,000. Finally, EntryPoint Capital LLC acquired a new position in GE HealthCare Technologies in the 4th quarter worth approximately $357,000. Institutional investors own 82.06% of the company’s stock.

GE HealthCare Technologies Price Performance

Shares of GE HealthCare Technologies stock opened at $82.46 on Wednesday. The stock has a market capitalization of $37.71 billion, a price-to-earnings ratio of 19.04, a P/E/G ratio of 3.19 and a beta of 1.13. The firm’s 50-day moving average price is $86.91 and its two-hundred day moving average price is $85.96. The company has a current ratio of 1.04, a quick ratio of 0.83 and a debt-to-equity ratio of 0.88. GE HealthCare Technologies Inc. has a 1-year low of $74.51 and a 1-year high of $94.80.

GE HealthCare Technologies (NASDAQ:GEHC) last released its quarterly earnings results on Thursday, February 13th. The company reported $1.45 EPS for the quarter, topping analysts’ consensus estimates of $1.26 by $0.19. GE HealthCare Technologies had a return on equity of 25.74% and a net margin of 10.13%. The business had revenue of $5.32 billion for the quarter, compared to analyst estimates of $5.33 billion. On average, equities analysts predict that GE HealthCare Technologies Inc. will post 4.68 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

Several brokerages have recently commented on GEHC. Wells Fargo & Company raised their target price on GE HealthCare Technologies from $96.00 to $103.00 and gave the stock an “overweight” rating in a research report on Friday, February 14th. The Goldman Sachs Group upgraded GE HealthCare Technologies from a “neutral” rating to a “buy” rating and upped their target price for the company from $85.00 to $100.00 in a report on Tuesday, March 11th. Jefferies Financial Group upgraded shares of GE HealthCare Technologies from a “hold” rating to a “buy” rating and upped their price objective for the company from $95.00 to $103.00 in a research note on Wednesday, January 8th. Finally, Citigroup lifted their target price on shares of GE HealthCare Technologies from $103.00 to $110.00 and gave the company a “buy” rating in a research note on Thursday, February 13th. One equities research analyst has rated the stock with a sell rating, two have given a hold rating, nine have assigned a buy rating and one has given a strong buy rating to the company. According to MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $98.75.

GE HealthCare Technologies Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.